Virlaza
Cerebremed
FR
La recherche
La recherche
LABPEI - Hot News | Virlaza™ inhibit cytokines release from airway epithelial cells in vitro
22 July 2021
medRxiv | Virlaza™ Inhibits Sars-COV-2-induced Inflammatory Response of Bronchial Epithelial Cells and Pulmonary Fibroblast

LABPEI - Hot news | Virlaza™ improves pulmonary, hematological and muscular recovery of post-covid-19 patient
17 July 2021
The ScienceGate | Virlaza Inhibits Sars-COV-2-induced Inflammatory Response of Bronchial Epithelial Cells and Pulmonary Fibroblast
4 June 2021
A Case Report | Virlaza™ Improves Cardiopulmonary Recovery of Post-Covid-19 Patient
11 February 2021
Report Virlaza™ in the Context of Lung Inflammation and Fibrosis in COVID-19
Virlaza
Cerebremed
Développement et recherche de la société "LibiPharm" - "LibiPharm" Israël.
Politique de confidentialité
© 2024 Calpton SIA. Tous droits réservés.
We accept
Conditions générales de vente
Contacts